BeStock  
Stocks › COLL

Collegium Pharmaceutical COLL

US equityMarket cap rank #3524
$21.97 +$0.04 (+0.18%)
Market open · Oct 8, 10:00 am ET · After hours $21.93 0.00%
Open$22.03
Prev close$21.93
Day range$21.80 – $22.03
Volume32.5K
Market cap$681.05M
P/E (TTM)17.3
Dividend yield–

COLL Stock News

Headlines matching Collegium Pharmaceutical or the COLL ticker, most recent first.

  • Truist Financial Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $49Market news · 9 Sep 2026 · Direct mention
  • Leerink Partners Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $45Market news · 9 Sep 2026 · Direct mention
  • H.C. Wainwright Reaffirms Their Buy Rating on Collegium Pharmaceutical (COLL)TipRanks · 22 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $60Market news · 22 Sep 2026 · Direct mention
  • Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Cuts Target Price to $43 NegativeMarket news · 7 Aug 2026 · Direct mention
  • Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $46 NegativeMarket news · 7 Aug 2026 · Direct mention
  • Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $48 NegativeMarket news · 19 Aug 2026 · Direct mention
  • Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $56Market news · 1 Jul 2026 · Direct mention
  • Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Myriad Genetics (MYGN) and Mineralys Therapeutics, Inc. (MLYS)TipRanks · 8 May 2026 · Direct mention
  • Truist Financial Maintains Collegium Pharmaceutical(COLL.US) With Buy RatingMarket news · 15 May 2026 · Direct mention
  • Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $56Market news · 13 May 2026 · Direct mention
  • Analysts Are Bullish on These Healthcare Stocks: Collegium Pharmaceutical (COLL), Sionna Therapeutics, Inc. (SION) PositiveTipRanks · 13 May 2026 · Direct mention
  • H.C. Wainwright Sticks to Its Buy Rating for Collegium Pharmaceutical (COLL)TipRanks · 24 Apr 2026 · Direct mention
  • Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Maintains Target Price $44Market news · 23 Apr 2026 · Direct mention
  • A Quick Look at Today's Ratings for Collegium Pharmaceutical(COLL.US), With a Forecast Between $44 to $60Market news · 20 Mar 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on COLL.

Leave a comment

Scroll to Top